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Introduction
Analysis of tablets is an important part of quality control in pharmaceutical manufacturing. Near infrared spectrometry (NIRS) has proved useful for this assay, 1 but in recent years there has been a growing interest in Raman spectrometry for tablet analysis owing to the greater chemical specificity, larger penetration depths into the sample and sharper spectral features compared to NIRS. Furthermore, common nonaromatic, non-crystalline excipients are generally poor Raman scattering materials in comparison to active drug substances that are often small aromatic heterocycles.
Identifying active pharmaceutical ingredient (API) peaks, even if present in very low concentrations compared to the excipient, is therefore more likely to be achieved with
Raman spectrometry, than with NIR spectrometry. 2 Conventional backscatter Raman spectrometry, typically using laser beam diameters of 50 -500 m, has been used for the composition monitoring of pharmaceutical tablets. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In many applications, advantages have been demonstrated over alternative techniques, often for determination of high relative concentrations of the analyte (up to 90%). However, a number of authors have reported that the small volume of the tablet sampled by conventional Raman spectrometry can affect the accuracy and precision of the analysis. 3, 7, 14 In a number of studies, a rotating sample holder 6-7, 10-11, 13, 15, 17 or multiple-point irradiation 7, 14, 16 was employed to increase the sampling area and hence, improve the repeatability of the Raman measurements. In an on-line example, the sampling area was increased by measuring a stream of tablets moving underneath the Raman probe on a conveyor system. 17 Kim et al. reported the advantages of wide area illumination for backscatter Raman analysis of pharmaceutical tablets. 18 The study compared the performance of a Raman system that produced a 6 mm diameter spot size with that of a conventional Raman system with a 100 µm spot size, to determine naproxen in tablets over the concentration range of 58-79% m/m. When replicate measurements were made on the same tablet using both methods, a significant improvement in the repeatability of the analyte peak area was seen with the larger spot size. Wide area illumination Raman analysis was also shown to be successful for the quantitative measurement of the API in an intact capsule formulation. 19 
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Although an improvement over conventional optical configurations that employ a small laser spot size, wide area backscatter Raman spectrometry does not analyse the whole tablet. Matousek and Parker demonstrated that with a sample spot size of 4 mm, 88% of the backscatter Raman signal from a 4 mm thick tablet was generated in the top 1 mm layer and only 12% of the signal originated from the remaining 3 mm of sample. 20 Hence, backscatter Raman spectra of APIs can be dominated by Raman or fluorescence signals arising from the tablet coating or capsule. [21] [22] [23] [24] Research into Raman photon migration [25] [26] and novel sampling configurations [27] [28] has revealed that many of the problems associated with backscatter Raman are removed when transmission Raman is used, and the attributes of the technique for analysis of pharmaceutical tablets and capsules are now being demonstrated. 20, 22, 24, [29] [30] [31] [32] The absence of sub-sampling limitations in transmission Raman spectroscopy has been illustrated by numerical simulations 20 and experimental investigations. 20, [33] [34] [35] [36] Matousek and Parker showed that when a 0.5 mm thick inter-layer was moved from the sample surface to a depth of 3 mm within a tablet medium, the simulated backscatter Raman signal decreased by four orders of magnitude. 20 In comparison, numerical 20, 34 and experimental [34] [35] [36] investigations showed that the signal was only weakly dependent on the depth of the inter-layer in transmission mode; a reduction in signal was observed when the inter-layer was located at the sample surface owing to loss of laser and Raman photons at the air-sample interface. Elimination of the sub-sampling problem in transmission mode measurements has also been illustrated experimentally using two-layer tablets. 20, 33 While backscatter Raman spectra were dominated by signals from the material that was irradiated directly by the laser, transmission Raman spectra contained signals from the two materials for both tablet orientations.
There have been some reported applications of transmission Raman spectrometry for quantification of an API in pharmaceutical tablets. In most cases, the calibration and sample tablets had the same composition and physical properties, which simplified the m/m) in a formulation containing three excipients in capsules of different sizes and fill level. Spectra were baseline corrected and normalised to unit length to account for variations in the transmission Raman signal intensity arising from differences in the amount of material within the capsules. Consequently, it was possible to use a PLS model developed using 100 mg capsules to predict the API content in 100 -400 mg capsules with a relative error of less than 3%.
Recently, transmission and backscatter Raman spectrometries were compared for quantification of two polymorphic forms (I and III) of flufenamic acid. 38 Spectra were pre-processed using a multiplicative scatter correction. 
High performance liquid chromatography (HPLC)
A Waters 660 pump with a 626S controller, in-line degasser, 717 autosampler and diode array detector were used. Data were acquired and processed using Waters 
Raman spectrometry
A Kaiser Raman Workstation and PhAT probe (Kaiser Optical systems, Ann
Arbor, USA) were used for tablet analysis in the backscatter and transmission modes. An
Invictus diode laser was employed, which has a wavelength of 785 nm and was operated at 400 mW at the source. For backscatter measurements, the tablets were illuminated from above using the PhAT probe with a laser beam optically expanded to give a 3 mm spot size. For transmission measurements, the tablets were illuminated from below using a laser spot that had been expanded to 3 mm diameter and transmitted Raman photons Calibration plots were produced using the intensity of the chlorpheniramine maleate peak at 1594 cm -1 , from both sides of each tablet, scaled to account for fluctuations in laser power. The scaling factor for each spectrum was calculated from the intensity of the Avicel peak at 1095.5 cm -1 in the 2 nd derivative spectrum of the first calibration tablet analysed divided by the Avicel peak intensity in the spectrum of subsequent calibration tablets. All the calibration plots had R 2 values between 0.98 and 0.99. Similarly, the intensity of the chlorpheniramine maleate peak in the Chlortrimeton tablets was scaled using the lactose 40 excipient peak at 1142.5 cm -1 in the 2 nd derivative spectrum of the first tablet analysed divided by the lactose peak intensity in the spectrum of subsequent sample tablets. The scaled peak intensities were then used to calculate the mass of chlorpheniramine maleate in the Chlortrimeton tablets.
Results

HPLC analysis
254 tablets were individually weighed and analysed to determine the mass of chlorpheniramine maleate in each tablet. A summary of the results is given in Table 1 Skewness and kurtosis statistics show that the data for the tablet mass, and API mass and concentration are not normally distributed. The API data are skewed to the right and are long tailed, which means that there is an enhanced probability of a tablet containing a high API content compared to a normal distribution. As the Chlortrimeton tablets are intended to be taken four times daily for a prolonged period, the variation in the amount of chlorpheniramine maleate contained in the tablets is of no pharmaceutical consequence. The results suggest, however, that better control of the manufacturing process could be achieved and in this regard direct spectroscopic analysis at the blending and tableting steps has potential advantages over HPLC, which is destructive and time consuming.
Raman spectrometry
Spectra of both sides of a tablet with heterogeneous distribution of chlorpheniramine maleate. A calibration tablet was prepared with a heterogeneous distribution of chlorpheniramine maleate (6.59 mg in a mass of Avicel corresponding to 4.95% m/m analyte) and both sides of the tablet were analysed by backscatter and transmission
Raman spectrometry. The spectra in Figure 3a show that in the backscatter mode, the heterogeneous distribution of chlorpheniramine maleate results in spectra of different intensity from the two sides of the tablet. In contrast, the transmission mode spectra 12 ( Figure 3b ) are more similar in intensity. Backscatter Raman maps acquired of both sides of the tablet using the PhAT probe showed that one surface of the tablet was rich in chlorpheniramine maleate whereas the other side was predominantly excipient. Hence, the results obtained are similar to those reported for the analysis of two-layer tablets using backscatter and transmission Raman measurements. 20, 33 It can be concluded that backscatter Raman is better at indicating differences in the amount of a compound on different sides of a tablet (i.e. heterogeneity), whereas transmission Raman should be better for whole tablet quantitative analysis. respectively. 39 The average mass of the API predicted by backscatter and transmission Raman spectrometry using the calibration tablets prepared from each grade of Avicel are shown in Table 2 . The effect of the particle size of Avicel on the accuracy of the estimated mass of chlorpheniramine maleate in the Chlortrimeton tablets is much greater for the transmission Raman measurements than for backscatter Raman. The calibration tablets made using Avicel PH-200 gave the most accurate prediction of chlorpheniramine maleate by transmission Raman suggesting that the photon transmission properties of 16 The relative insensitivity of wide area backscatter measurements to differences in particle size between the calibration and sample tablets is consistent with previous findings. 42 Hu et al. attributed the insensitivity of wide area (3 mm laser spot size)
Analysis of Chlortrimeton tablets using external calibration tablets.
backscatter Raman measurements, compared to measurements made using a 60 m laser spot size, to the increased sampling volume being much greater than the sample particle size. 42 Although the sampling volume of transmission Raman measurements far exceeds that of backscatter Raman measurements, which are dominated by the initial 1 mm or so of a tablet, 20 previous studies have shown that the propagation of photons in the transmission mode is significantly affected by variations in the size and type of particles. 36, 43 The relatively minor effect of particle size on the backscatter Raman spectra arises because most of the signal originates from the surface. 20 Particle size affects the surface smoothness and it may be that this is best matched to the sample tablets in this study when the calibration tablets are prepared from Avicel PH-101.
In previous studies where the chemical composition and the physical properties of the sample and calibration tablets were matched, any effects of variations in the amount of material measured on the transmission Raman signal were reduced through normalisation procedures based on calculation of relative intensities. Although it is generally best to matrix-match the sample and calibration tablets, this is not always possible, especially if the sample tablet composition is not known accurately. This part of the study demonstrated that although transmission Raman measurements are more representative of the whole sample, in contrast to backscatter, it is more likely that inaccurate estimations of the analyte mass/concentration will arise if the external calibration set is not well matched to the sample set in terms of photon propagation characteristics. This is a conclusion that has not been mentioned in previous studies of 18 transmission Raman spectrometry. Addition of an internal standard can mitigate against matrix differences between samples and calibrants, but is generally destructive 10 and not suitable for direct analysis of tablets.
Comparison of Raman and HPLC analyses
A sub-set of 25 Chlortrimeton tablets analysed by both Raman modes was also Previous work by the authors has shown that the physical properties of a powder (e.g. particle size) have a significant effect on the propagation of laser and Raman photons generated in the transmission mode. 36 The results of the present investigation illustrate the analytical consequences of these prior observations for the analysis of tablets. It has been shown that transmission Raman spectrometry can be used to quantify accurately the content of chlorpheniramine maleate at the 2% m/m level in a pharmaceutical tablet product when external calibration tablets are prepared from microcrystalline cellulose (Avicel), provided the photon propagation characteristics of the sample and calibration tables are matched. Backscatter Raman can also be used successfully for this analysis and is less susceptible to particle size effects. In previous Raman studies, the effects of physical properties such as particle size were either not explored or considered to be less significant than for near infrared spectrometry. 32 This study indicates that this is not the case. Nonetheless, both Raman methods have advantages over HPLC which is often the standard method for API analysis, but it takes longer and involves destruction of the sample tablets.
If preparation of calibration tablets with photon propagation properties similar to the samples is not easily achieved, a reference method such as HPLC could be used to construct calibration models for the Raman analysis. However, it is likely that the API would need to be added to a selection of sample tablets to extend the calibration range as the mass range of API in commercial samples is normally relatively small. Recently there have been some advances in spectral pre-processing procedures for the removal of the effects of particle size from Raman spectra acquired in backscatter mode. 44 Such procedures could be extended to provide similar benefits in transmission Raman spectrometry, particularly when it is not possible to use calibration and sample tablets with the same chemical composition.
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